Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Indolelactic acid

Indolelactic acid Sale

(Synonyms: 3-吲哚乳酸,Indole-3-lactic acid) 目录号 : GC33659

Indolelactic acid(Indole-3-lactic acid)是一种由色氨酸衍生的微生物代谢物,主要由肠道菌群产生。它作为信号分子参与调节宿主免疫反应和维持肠道稳态,具有抗炎特性,并在代谢通路和肠-脑轴通讯中发挥重要作用。

Indolelactic acid Chemical Structure

Cas No.:1821-52-9

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥432.00
现货
5mg
¥393.00
现货
10mg
¥630.00
现货
25mg
¥1,170.00
现货
50mg
¥1,890.00
现货
100mg
¥3,213.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

101

客户使用产品发表文献 1

Description

Indolelactic acid (Indole-3-lactic acid) is a tryptophan-derived microbial metabolite primarily produced by the gut microbiota. Indolelactic acid functions as a signaling molecule to modulate host immune responses and maintain gut homeostasis, exhibiting anti-inflammatory properties and playing a significant role in metabolic pathways and gut-brain axis communication[1]. Indolelactic acid has a structure that includes an indole ring and a lactic acid moiety. Indolelactic acid acts as a ligand for the aryl hydrocarbon receptor (AhR), regulating the differentiation of immune cells and the secretion of cytokines. ILA exhibits anti-inflammatory, antiviral, and anti-tumor activities[2, 3, 4].

In vitro experiments have shown that Indolelactic acid (100μM) can enhance the activation of AhR and the nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2) in human intestinal epithelial cells. Indolelactic acid reduces endotoxin-induced macrophage activation and the release and expression of IL-8 in intestinal epithelial cells[5]. Indolelactic acid also accelerates the production of IL12a in dendritic cells by enhancing the binding of H3K27ac at the enhancer regions of IL12a, which contributes to priming CD8+ T cell immunity against tumor growth[6].

In vivo, daily oral administration of Indolelactic acid (20mg/kg) to C57BL/6 mice with colitis downregulates the levels of TNF-α, IL-6, and IL-22, significantly alleviating intestinal inflammation and restoring the diversity of the gut microbiota[7]. In mouse models, oral administration of Indolelactic acid (35mg/kg/day) reduces neuroinflammation and improves motor function through an aldehyde dehydrogenase (ALDH)-dependent pathway, exerting antidepressant effects[8].

References:
[1] Yu K, Li Q, Sun X, et al. Bacterial indole-3-lactic acid affects epithelium-macrophage crosstalk to regulate intestinal homeostasis. Proc Natl Acad Sci U S A. 2023 Nov 7;120(45):e2309032120.
[2] Zhang FL, Chen XW, Wang YF, et al. Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia/reperfusion injury via positive regulation of YAP and Nrf2. J Transl Med. 2023 Apr 18;21(1):264.
[3] Kim H, Lee E, Park M, et al. Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation. Brain Behav Immun. 2024 Nov;122:568-582.
[4] Li Y, Li Q, Yuan R, et al. Bifidobacterium breve-derived indole-3-lactic acid ameliorates colitis-associated tumorigenesis by directing the differentiation of immature colonic macrophages. Theranostics. 2024 Apr 22;14(7):2719-2735.
[5] Ehrlich AM, Pacheco AR, Henrick BM, et al. Raybould HE. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020 Nov 23;20(1):357.
[6] Zhang Q, Zhao Q, Li T, et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity. Cell Metab. 2023 Jun 6;35(6):943-960.
[7] Zhang S, Nie Q, Sun Y, et al. Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome. 2024 Sep 19;12(1):177.
[8] Qian X, Li Q, Zhu H, Chen Y, et al. Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation. Cell Rep Med. 2024 Nov 19;5(11):101798.

Indolelactic acid(Indole-3-lactic acid)是一种由色氨酸衍生的微生物代谢物,主要由肠道菌群产生。它作为信号分子参与调节宿主免疫反应和维持肠道稳态,具有抗炎特性,并在代谢通路和肠-脑轴通讯中发挥重要作用[1]。Indolelactic acid的结构包含吲哚环与乳酸基团,能够作为芳烃受体(AhR)的配体,调节免疫细胞分化和细胞因子分泌,具有抗炎、抗病毒以及抗肿瘤的活性[2, 3, 4]

体外实验中,Indolelactic acid(100μM)可增强人肠道上皮细胞的AhR和核因子(红细胞衍生2)相关因子2(Nrf2)的激活,Indolelactic acid降低内毒素诱导的巨噬细胞活化,以及肠上皮细胞中 IL-8 的释放和表达[5]。Indolelactic acid通过增强 IL12a 增强子区域的 H3K27ac 结合来加速树突状细胞中 IL12a 的产生,这有助于激发 CD8 T 细胞对肿瘤生长的免疫力 [6]

在体内,对结肠炎模型C57BL/6小鼠每日口服Indolelactic acid(20mg/kg),可下调TNF-α、IL-6和IL-22的水平,显著减轻肠道炎症,并恢复肠道菌群多样性[7]。在小鼠模型中,口服Indolelactic acid(35mg/kg/day)通过乙醛脱氢酶(ALDH)依赖性通路减少神经炎症,改善运动功能,发挥抗抑郁的作用[8]

实验参考方法

Cell experiment [1]:

Cell lines

RAW-Blue, Caco-2, HT-29

Preparation Method

Indolelactic acid was added to RAW-Blue, Caco-2, HT-29 cells 1 hour prior to exposure to LPS. The cells were then incubated with LPS for 4 hours. Caco-2 and HT-29 cells were incubated with ILA in the presence of TNF-α for 1 hour.

Reaction Conditions

0.01mM, 0.1mM, 1mM, 10mM, 1h

Applications

Indolelactic acid reduces endotoxin-induced RAW-Blue activation, as well as the release and expression of IL-8 in Caco-2 and HT-29.
Animal experiment [2]:

Animal models

C57BL/6 mice

Preparation Method

Five-week-old male C57BL6 mice were treated with 20mg/kg of Indolelactic acid by daily gavage for 14 days, and 3% (w/v) DSS was added to the drinking water from day 7 to day 14.

Dosage form

20mg/kg/day for 14 days; i.g.

Applications

Indolelactic acid downregulates the levels of TNF-α, IL-6, and IL-22, significantly alleviates intestinal inflammation, and restores the diversity of the gut microbiota.

References:
[1] Ehrlich AM, Pacheco AR, Henrick BM, et al. Raybould HE. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020 Nov 23;20(1):357.
[2] Zhang S, Nie Q, Sun Y, et al. Bacteroides uniformis degrades ?-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome. 2024 Sep 19;12(1):177.

化学性质

Cas No. 1821-52-9 SDF
别名 3-吲哚乳酸,Indole-3-lactic acid
Canonical SMILES OC(C(CC1=CNC2=CC=CC=C12)O)=O
分子式 C11H11NO3 分子量 205.21
溶解度 DMSO : 86.67 mg/mL (422.35 mM) 储存条件 Store at 2-8°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 4.8731 mL 24.3653 mL 48.7306 mL
5 mM 0.9746 mL 4.8731 mL 9.7461 mL
10 mM 0.4873 mL 2.4365 mL 4.8731 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: